DCM
HSTO

DAFNA Capital Management’s Histogen Inc. Common Stock HSTO Stock Holding History

DAFNA Capital Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-250
Closed -$288K – 83
2017
Q2 		$288K Buy
+250
New +$304K 0.21% 61
2014
Q1 		– Sell
-678
Closed -$875K – 52
2013
Q4 		$875K Buy
678
+100
+17% +$160K 0.9% 25
2013
Q3 		$1.16M Buy
+578
New +$1.07M 1.27% 18

Other funds holding HSTO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DAFNA Capital Management's HSTO Position: Q3 2017 in Review

DAFNA Capital Management sold out of Histogen Inc. Common Stock (HSTO) in Q3 2017, closing a stake of 250 shares — an estimated $288K sold.

DAFNA Capital Management first reported a position in HSTO in Q3 2013 and held it in 3 quarters. The position peaked at $1.16M in Q3 2013. 78 funds tracked by Wall St. Rank hold HSTO as of Q3 2017.

  • DAFNA Capital Management reported no remaining Histogen Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • DAFNA Capital Management sold 250 Histogen Inc. Common Stock shares in Q3 2017, an estimated $288K.
  • DAFNA Capital Management first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • DAFNA Capital Management's Histogen Inc. Common Stock position peaked at $1.16M in Q3 2013.
  • 78 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2017.

Based on DAFNA Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.